Ear Sensor Enables Safe Telemedical Care for COVID-19 Risk Patients

Using telemedicine, COVID-19 patients can be cared for safely at home - from initial home isolation to recovery or, in case problems arise, admission to hospital. A team from the Technical University of Munich (TUM) has now successfully demonstrated this in a study involving 150 patients with risk factors for a severe progression of the disease.

COVID-19 patients are required to go into home isolation. But this can be dangerous for high-risk patients if they develop a severe progression during isolation. In this case, timely admission to the hospital for treatment can be critical for survival. Unfortunately, many COVID-19 patients do not immediately notice when their condition starts to deteriorate. The alternative of playing safe by admitting all at-risk patients immediately upon diagnosis would overburden the clinics.

Small effort - large gain in safety

During the recent Corona waves, Georg Schmidt and his team provided telemedical care to more than 150 patients with risk factors for a severe progression of the disease using an ear sensor that is easily worn behind the ear like a hearing aid.

The sensor recorded all important values such as body temperature, heart rate, respiration rate, and oxygen saturation in 15-minute intervals and transmitted the data to the telemedicine center at TUM’s university hospital Klinikum rechts der Isar. There, the team continuously monitored all incoming data. In addition, each participant was called at least once a day to inquire about his or her condition.

Whenever the team noticed a deterioration in the readings, they called the patient. A physician then took a decision on whether hospitalization was indicated. With minimal effort, the team achieved a quality of monitoring quite comparable to that at a hospital.

Great patient satisfaction

Around one in eight participants had to be admitted during the study. Interestingly, most of these patients later stated that they did not themselves realize the degree of deterioration in their condition.

"To our knowledge, this is the first study worldwide to continuously monitor patients in home isolation remotely and to prompt immediate hospitalization in the event of critical health deterioration," said Prof. Georg Schmidt, head of the Biosignal Processing Group at the Klinikum rechts der Isar.

The study illustrates that COVID-19 risk patients can be monitored effectively using telemedicine, potentially saving valuable resources in future waves of infection. Patients were also very satisfied and felt significantly safer thanks to the continuous monitoring.

Wurzer D, Spielhagen P, Siegmann A, Gercekcioglu A, Gorgass J, Henze S, Kolar Y, Koneberg F, Kukkonen S, McGowan H, Schmid-Eisinger S, Steger A, Dommasch M, Haase HU, Müller A, Martens E, Haller B, Huster KM, Schmidt G.
Remote monitoring of COVID-19 positive high-risk patients in domestic isolation: A feasibility study.
PLoS One. 2021 Sep 24;16(9):e0257095. doi: 10.1371/journal.pone.0257095

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...